Yanhua Zuo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The purpose of this study is to investigate the anti-angiogenic activities of NSK-01105, a novel sorafenib derivative, in in vitro, ex vivo and in vivo models, and explore the potential mechanisms. NSK-01105 significantly inhibited vascular endothelial growth factor (VEGF)-induced migration and tube formation of human umbilical vein endothelial cells at(More)
  • 1